Sanofi launches $69 per share bid for Genzyme; $17.5bn value
- Gene Therapy, Cell Therapy
- Large Molecule
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Includes Earnout
- Full Acquisition
- Payment Includes Cash
- Includes Contract
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.